Federal contractor · public award history
GLENMARK PHARMACEUTICALS INC., USA
Parent: GLENMARK PHARMACEUTICALS LIMITED RGNERL2TNWT8
- Awards we know about
- 2
- Typical size
- —
- Middle of their public awards
- Dollars on those awards
- $0
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Apr 9, 2027
- Activation date
- Apr 9, 2026
- Primary NAICS (SAM)
- 325412
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (2)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
NEW AWARD FOR APREPITANT CAPSULES WITH GLENMARK PHARMACEUTICALS, INC., USA. PERIOD OF PERFORMANCE IS NOVEMBER 1, 2020 THROUGH OCTOBER 31, 2021 WITH FOUR ONE YEAR OPTIONS.
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.